Biogen (BIIB) Payables (2009 - 2026)
Biogen (BIIB) recorded Payables of $403.9 million in Q2 2026, down 1.1% from $408.4 million a year earlier but up 12.7% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen reported Payables of $432 million, down 80.1% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
- Across earlier years, Payables came in at $2.17 billion in FY2024 (+292.7%), $553.3 million in FY2023 (+12.6%), $491.5 million in FY2022 (-69.1%) and $1.59 billion in FY2021 (+249.2%).
- Quarterly Payables has ranged from $354.5 million in Q2 2024 to $2.17 billion in Q4 2024 over the past five years.
- On a year-over-year basis, Payables has declined for four consecutive quarters, with growth averaging 53.7% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 292.7% in Q4 2024, against a decline of 83.3% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $358.5 million (Q1 2026), $432 million (Q4 2025) and $413.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn | 403.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 403.90 Mn |
| Mar 31, 2026 | 358.50 Mn |
| Dec 31, 2025 | 432.00 Mn |
| Sep 30, 2025 | 413.10 Mn |
| Jun 30, 2025 | 408.40 Mn |
| Mar 31, 2025 | 2.14 Bn |
| Dec 31, 2024 | 2.17 Bn |
| Sep 30, 2024 | 2.17 Bn |
| Jun 30, 2024 | 354.50 Mn |
| Mar 31, 2024 | 637.00 Mn |
| Dec 31, 2023 | 553.30 Mn |
| Sep 30, 2023 | 940.10 Mn |
| Jun 30, 2023 | 445.40 Mn |
| Mar 31, 2023 | 491.20 Mn |
| Dec 31, 2022 | 491.50 Mn |
| Sep 30, 2022 | 383.20 Mn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.40 Bn |
| Dec 31, 2021 | 1.59 Bn |
| Sep 30, 2021 | 1.43 Bn |
API Access
Biogen Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();